investor login

contact

team

dedicated funds

news

 portfolio

Curoverse developed a genomic and biomedical computing platform designed to help researchers and clinicians manage, analyze, and securely share massive datasets—from sequencing to medical imaging—to accelerate drug development and precision medicine. Its open-source Arvados platform enables scalable processing of terabyte- to petabyte-scale biomedical data across cloud and on-premise environments.

Acquired by Veritas Genetics in August 2017.

 
VISIT WEBSITE

Exited/Public, Health Tech, HVP IV, Portfolio

back to portfolio

contact

© hatteras venture partners | all rights reserved | terms + privacy | site credit

 team

 portfolio

news

home

Hatteras Venture Partners is a venture capital firm that builds transformational companies in areas of health innovation.

dedicated funds

contact

 team

dedicated funds

news

home

 portfolio